enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The first pill to treat postpartum depression has been ... - AOL

   www.aol.com/news/fda-approves-first-postpartum...

   The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 ...

3. The first oral pill to treat postpartum depression is ... - AOL

   www.aol.com/lifestyle/fda-approved-pill-treat...

   Zurzuvae is the first oral medication for postpartum depression. The first oral pill to treat postpartum depression is expected to be available in December — and cost nearly $16,000 without ...

4. FDA approves first postpartum depression pill in the US - AOL

   www.aol.com/fda-approves-first-postpartum...

   The US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral ...

5. The first pill for postpartum depression is finally getting ...

   www.aol.com/first-pill-postpartum-depression...

   The first-ever pill for postpartum depression, zuranolone, was approved last year. Doctors are starting to prescribe it to patients, with positive results. The first pill for postpartum depression ...

6. Oxytocin treatment for postpartum depression - Wikipedia

   en.wikipedia.org/wiki/Oxytocin_Treatment_for...

   Oxytocin (OT) has potential to be a treatment for postpartum depression (PPD). Oxytocin is released when a mother cares for her child, making the interaction pleasurable [2] . Mothers that report high levels of infant-mother bonding and demonstrate responsive and sensitive parenting generally show increased levels of OT and brain reward center ...

7. A new $16,000 postpartum depression drug is here. How will ...

   www.aol.com/16-000-postpartum-depression-drug...

   A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...